Business Description
Vectus Biosystems Ltd
ISIN : AU000000VBS9
Description
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 28.84 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.7 | |||||
3-Year EPS without NRI Growth Rate | 17.2 | |||||
3-Year FCF Growth Rate | 27.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.45 | |||||
9-Day RSI | 40.44 | |||||
14-Day RSI | 33.21 | |||||
6-1 Month Momentum % | -69.31 | |||||
12-1 Month Momentum % | -79.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.71 | |||||
Quick Ratio | 3.71 | |||||
Cash Ratio | 2.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31 | |||||
Shareholder Yield % | 136.94 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -391200 | |||||
Net Margin % | -248800 | |||||
FCF Margin % | -138200 | |||||
ROE % | -69.58 | |||||
ROA % | -54.53 | |||||
ROIC % | -259.07 | |||||
ROC (Joel Greenblatt) % | -313.26 | |||||
ROCE % | -68.52 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.82 | |||||
Price-to-Tangible-Book | 1.82 | |||||
EV-to-EBIT | -0.6 | |||||
EV-to-EBITDA | -0.61 | |||||
EV-to-Revenue | 1483 | |||||
EV-to-FCF | -1.07 | |||||
Price-to-Net-Current-Asset-Value | 2.05 | |||||
Price-to-Net-Cash | 4.1 | |||||
Earnings Yield (Greenblatt) % | -166.67 | |||||
FCF Yield % | -31.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vectus Biosystems Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.001 | ||
EPS (TTM) (A$) | -0.044 | ||
Beta | 1.24 | ||
Volatility % | 62.13 | ||
14-Day RSI | 33.21 | ||
14-Day ATR (A$) | 0.005375 | ||
20-Day SMA (A$) | 0.08595 | ||
12-1 Month Momentum % | -79.77 | ||
52-Week Range (A$) | 0.076 - 0.5 | ||
Shares Outstanding (Mil) | 53.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vectus Biosystems Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vectus Biosystems Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Vectus Biosystems Ltd Frequently Asked Questions
What is Vectus Biosystems Ltd(ASX:VBS)'s stock price today?
The current price of ASX:VBS is A$0.08. The 52 week high of ASX:VBS is A$0.50 and 52 week low is A$0.08.
When is next earnings date of Vectus Biosystems Ltd(ASX:VBS)?
The next earnings date of Vectus Biosystems Ltd(ASX:VBS) is .
Does Vectus Biosystems Ltd(ASX:VBS) pay dividends? If so, how much?
Vectus Biosystems Ltd(ASX:VBS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |